Evaluations of bioactive poly(ε-caprolactone)-organosiloxane nano-hybrid as a material for bone repair

Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 4-11, 2009, Pages 445-452

  Yoo, Jeong Joon ^a   Rhee, Sang Hoon ^a   Lee, Jae Il ^a   Kim, Hee Joong ^a  

^a Seoul National University   (South Korea)

Author keywords

Bioactivity; Bone repair; Osteoconduction; Polycaprolactone; Siloxane

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; BONE REPAIR; FOREIGN BODY REACTIONS; HUMAN BONE MARROW STROMAL CELLS; NANO-HYBRID MATERIALS; OSTEOCONDUCTION; SILOXANE; STRUCTURAL MODIFICATIONS;

APATITE; BIOACTIVITY; BONE; HYBRID MATERIALS; PHOSPHATASES; TISSUE CULTURE;

POLYCAPROLACTONE;

EID: 79960187146     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. CJ Damien, JR Parsons, Bone graft and bone graft substitutes: a review of current technology and applications, J Appl Biomater, 2, 187 (1991).
2. J Glowacki, JB Mulliken, Demineralized bone implants, Clin Plast Surg, 12, 233 (1985)
3. BE Buck, TI Malinin, MD Brown, Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome(AIDS), Clin Orthop Relat Res, 240, 129 (1989).
4. DW Hutmacher, Scaffold design and fabrication technologies for engineering tissues-state of the art and future perspectives, J Biomater Sci Polym Ed, 12, 107 (2001).
5. SL Ishaug, GM Crane, MJ Miller, et al., Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds, J Biomed Mater Res, 36, 17 (1997).
6. K Whang, KE Healy, DR Elenz, et al., Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture, Tissue Eng, 5, 35 (1999).
7. Q Chen, F Miyaji, T Kokubo, et al., Apatite formation on PDMS-modified CaO-SiO2-TiO2 hybrids prepared by sol-gel process, Biomaterials, 20, 1127 (1999).
8. Q Chen, N Miyata, T Kokubo, et al., Bioactivity and mechanical properties of PDMS-modified CaO-SiO(2)-TiO(2) hybrids prepared by sol-gel process, J Biomed Mater Res, 51, 605 (2000).
9. Q Chen, N Miyata, T Kokubo, et al, Effect of heat treatment on bioactivity and mechanical properties of PDMS-modified CaO-SiO2-TiO2 hybrids via sol-gel process, J Mater Sci Mater Med, 12, 515 (2001).
10. M Kamitakahara, M Kawashita, T Kokubo, et al., Effect of polyacrylic acid on the apatite formation of a bioactive ceramic in a simulated body fluid: fundamental examination of the possibility of obtaining bioactive glass-ionomer cements for orthopaedic use, Biomaterials, 22, 3191 (2001).
11. N Miyata, K Fuke, Q Chen, et al., Apatite-forming ability and mechanical properties of PTMO-modified CaO-SiO2 hybrids prepared by sol-gel processing: effect of CaO and PTMO contents, Biomaterials, 23, 3033 (2002).
12. N Miyata, K Fuke, Q Chen, et al., Apatite-forming ability and mechanical properties of PTMO-modified CaO-SiO2-TiO2 hybrids derived from sol-gel processing, Biomaterials, 25, 1 (2004).
13. SH Rhee, Effect of calcium salt content in the poly(epsiloncaprolactone)/ silica nanocomposite on the nucleation and growth behavior of apatite layer, J Biomed Mater Res A, 67, 1131 (2003).
14. SH Rhee, Bone-like apatite-forming ability and mechanical properties of poly(epsilon-caprolactone)/silica hybrid as a function of poly(epsilon- caprolactone) content, Biomaterials, 25, 1167 (2004).
15. SH Rhee, JY Choi, HM Kim, Preparation of a bioactive and degradable poly(epsilon-caprolactone)/silica hybrid through a sol-gel method, Biomaterials, 23, 4915 (2002).
16. SH Rhee, YK Lee, BS Lim, et al., Evaluation of a novel oly(epsilon-caprolactone)-organosiloxane hybrid material for the potential application as a bioactive and degradable bone substitute, Biomacromolecules, 5, 1575 (2004).
17. JJ Yoo, SH Rhee, Evaluations of bioactivity and mechanical roperties of poly (epsilon-caprolactone)/silica nanocomposite following heat treatment, J Biomed Mater Res A, 68, 401 (2004).
18. JJ Yoo, JE Lee, HJ Kim, et al., Comparative in vitro and in vivo studies using a bioactive poly(epsilon-caprolactone)-organosiloxane nanohybrid containing calcium salt, J Biomed Mater Res B Appl Biomater, 83, 189 (2007).
19. P Ducheyne, Q Qiu, Bioactive ceramics: the effect of surface eactivity on bone formation and bone cell function, Biomaterials, 20, 2287 (1999).
20. C Loty, JM Sautier, H Boulekbache, et al., In vitro bone formation on a bone-like apatite layer prepared by a biomimetic process on a bioactive glass-ceramic, J Biomed Mater Res, 49, 423 (2000).
21. H Ohgushi, Y Dohi, T Yoshikawa, et al., Osteogenic differentiation of cultured marrow stromal stem cells on the surface of bioactive glass ceramics, J Biomed Mater Res, 32, 341 (1996).
22. M Okumura, H Ohgushi, Y Dohi, et al., Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics, J Biomed Mater Res, 37, 122 (1997).
23. S Radin, G Reilly, G Bhargave, et al., Osteogenic effects of bioactive glass on bone marrow stromal cells, J Biomed Mater Res A, 73, 21 (2005).
24. MF Pittenger, AM Mackay, SC Beck, et al., Multilineage otential of adult human mesenchymal stem cells, Science, 284, 143 (1999).
25. F Causa, PA Netti, L Ambrosio, et al., Poly-epsiloncaprolactone/ hydroxyapatite composites for bone regeneration: In vitro characterization and human osteoblast response, J Biomed Mater Res A, 76, 151 (2006).
26. RS Bezwada, DD Jamiolkowski, IY Lee, et al., Monocryl suture, a new ultra-pliable absorbable monofilament suture, Biomaterials, 16, 1141 (1995).
27. PD Darney, SE Monroe, CM Klaisle, et al., Clinical evaluation of the Capronor contraceptive implant: preliminary report, Am J Obstet Gynecol, 160, 1292 (1989).
28. D Rohner, DW Hutmacher, TK Cheng, et al., In vivo efficacy of bone-marrow-coated polycaprolactone scaffolds for the reconstruction of orbital defects in the pig, J Biomed Mater Res B Appl Biomater, 66, 574 (2003).
29. H Kweon, MK Yoo, IK Park, et al., A novel degradable polycaprolactone networks for tissue engineering, Biomaterials, 24, 801 (2003).
30. KG Marra, JW Szem, PN Kumta, et al., In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering, J Biomed Mater Res, 47, 324 (1999).
31. JM Williams, A Adewunmi, RM Schek, et al., Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering, Biomaterials, 26, 4817 (2005).
32. Z Xia, H Ye, C Choong, et al., Macrophagic response to human mesenchymal stem cell and poly(epsilon-caprolactone) implantation in nonobese diabetic/severe combined immunodeficient mice, J Biomed Mater Res A, 71, 538 (2004).
33. FR Tay, DH Pashley, CK Yiu, et al., Susceptibility of a polycaprolactone-based root canal filling material to degradation. II. Gravimetric evaluation of enzymatic hydrolysis, J Endod, 31, 737 (2005).
34. SH Kim, Y Jung, SH Kim, et al., Chondrogenic differentiation of human adipose tissue-derived stem cells on PLCL/fibrin hybrid scaffolds, Tissue Eng Regen Med, 6(1∼3), 313 (2009).
35. JY Kim, JJ Yoon, EK Park, et al., The fabrication of rapid prototype based 3D PCL and PLGA scaffolds using precision deposition system, Tissue Eng Regen Med, 5(3), 506 (2008).
36. G Khang, SH Kim, MS Kim, et al., Recent and future directions of stem cells for the application of regenerative medicine, Tissue Eng Regen Med, 4(4), 441 (2007).
37. JT Ko, JH Lee, JM Kim, et al., Development of biodegradable methoxy poly(ethyleneglycol)-polyesters diblock copolymers as drug carrier for implantable disc, Tissue Eng Regen Med, 3(2), 158 (2006).
38. KS Seo, KD Hong, H Hyun, et al., Sustained release of proteins using temperature sensitive MPEG-PCL hydrogels, Tissue Eng Regen Med, 2(2), 109 (2005).
39. YH Cho, H Hyun, JH Lee, et al., Synthesis of triblock copolymers consisting of methoxy poly(ethylene glycol), poly(caprolactone), and poly(L-lactide-co-glycolide) and determination of critical micelle concentration, Tissue Eng Regen Med, 2(4), 368 (2005).
40. MH Cho, SK Kim, H Hyun, et al., Sustained release of BDNF using temperature sensitive MPEG-PCL hydrogels, Tissue Eng Regen Med, 3(1), 46 (2006).
41. JT Ko, JH Lee, JM Kim, et al., Development of biodegradable methoxy poly(ethyleneglycol)-polyesters diblock copolymers as drug carrier for implantable disc, Tissue Eng Regen Med, 3(2), 158 (2006).